TRIB Trinity Biotech
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
Company profile
Ticker
TRIB
Exchange
Website
CEO
Ronan O'Caoimh
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
TRIB stock data
()
Calendar
29 Apr 21
24 Jun 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from company earnings reports.
Institutional ownership Q1 2021
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
13F holders |
Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
13F shares |
Current |
|---|---|
| Total value | 0 |
| Total shares | 0 |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
Largest owners |
Shares | Value |
|---|
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abated, accessed, adapt, Addendum, adjoining, adjourned, adjudged, admitting, aesthetic, affix, aim, alia, alliance, Alphabet, annum, antibody, Arab, atypical, Austin, Ave, Avenue, banned, BD, Beacon, Benchmark, biochemistry, Biology, Bishopsgate, Bombay, Boston, bribing, BS, BSc, bulk, career, cast, CEBA, cent, CFG, CFO, chain, characterized, check, cleaning, codified, Colorado, combatting, composed, composition, contributor, Cooperation, Copan, corruptly, covid, CT, deferral, Denver, depict, detector, Devia, deviate, discharge, dishonesty, Display, disqualifying, dissolved, division, dossier, drilling, drop, dual, Dunne, Eastern, EKF, endorsement, Erba, ESG, essential, Ethical, EUA, expedite, factual, fallen, FD, Fernando, Fillmore, Floor, fluid, footnote, forgivable, forthwith, fullest, generalise, gillard, graduated, Greenwich, guest, Guideline, harbor, Harmonised, Heartland, heath, Helsinki, Hemagen, Henderson, hereto, hinder, home, honestly, hundred, hurdle, hygiene, ICH, Immunodeficiency, improperly, indemnify, inefficiency, infection, inflow, Inline, insolvency, instruct, instructed, instruction, interactive, ISIL, IVDR, john, Kelly, kind, laser, learning, leasehold, left, likelihood, Linkbase, lockdown, logistical, LP, Lynq, MA, macroeconomic, marker, mask, materialise, maximize, Maynooth, MBA, media, Mediterranean, Milwaukee, Mine, minimise, misfortune, mission, mixture, Molecular, neglect, Nicaragua, Nov, NUI, occasioned, occupied, omission, opportunity, opted, optimization, override, Paradice, PCR, pleasure, postmarket, priority, progressed, promise, promised, promptly, Putnam, PWC, qualification, rationale, regime, relinquish, remote, remotely, Renaissance, repeatability, resolve, restored, rollout, safeguard, sanitizer, Sanjiv, Schema, School, sector, shelf, shut, Simon, sixty, Smurfit, speed, statistical, stepped, stepping, stipulated, stockpiling, Stonehill, stream, stretched, suffice, Suri, susceptible, Syrian, Tabular, Taxonomy, telecommuting, Terence, therewith, threat, threatened, tied, timeframe, Timetable, traditional, UCD, Ukraine, unauthorized, unbooked, uncommercial, underpinning, unforgiven, unlimited, Unresolved, upcoming, UTM, vacated, vaccination, variance, Venezuela, verified, victim, vouch, wage, Water, wearing, whatsoever, Whitefort, WI, WMA, workplace, XBRL, xv
Removed:
abroad, AGM, allotment, amend, Aptose, Arizona, attaching, AVI, Bacteriology, barred, Berkeley, bid, bin, Biopharma, bona, borrowed, Burma, calling, cancer, carryforward, Clause, clearing, collateral, comprehensively, convert, converted, copied, Coyne, cull, cytotoxicity, declared, deem, deferring, denomination, deterioration, Diagnostica, difficile, diligently, disenfranchisement, dispute, District, divestiture, earnout, effectivity, elapse, entering, Epitope, Eritrea, evenly, exercising, extraordinary, failed, falling, fide, flood, formed, Guinea, headquartered, hiring, house, immaterial, implied, impracticality, improper, indicted, ineffectual, inquire, lactate, Laden, leave, Lebanon, Liberia, license, licensed, meaningful, medicinal, membership, merger, Microbiology, Milosevic, month, mortgage, motion, mutually, Myanmar, nationality, observed, Oncology, OraQuick, OraSure, ordering, Oregon, Osama, outlay, outline, pari, passing, passu, Peter, pledged, pneumoniae, poll, Portland, preventing, professorship, promissory, prompting, proposal, proscribed, purport, ranking, reaction, reconvert, recording, Reidy, removal, residence, resultant, retail, room, showed, slight, Slobodan, Somalia, Southern, speak, specialising, Stago, strongly, succeeded, suit, Surgery, Surgical, suspending, Syria, TBIL, tendered, therefrom, thought, transacted, transitional, Tribunal, TSA, TSX, twofold, uncalled, uncashed, underway, underwriting, unjustly, unremitted, variation, varied, vendor, vigorously, visiting, warrant, Washington, wilfully, Yugoslavia
Financial reports
20-F
2020 FY
Annual report (foreign)
29 Apr 21
20-F
2019 FY
Annual report (foreign)
15 Jun 20
20-F
2018 FY
Annual report (foreign)
14 May 19
20-F
2017 FY
Annual report (foreign)
19 Apr 18
20-F
2016 FY
Annual report (foreign)
23 Apr 17
20-F
2015 FY
Annual report (foreign)
7 Apr 16
20-F
2014 FY
Annual report (foreign)
24 Mar 15
20-F
2013 FY
Annual report (foreign)
8 Apr 14
20-F
2012 FY
Annual report (foreign)
4 Apr 13
20-F
2011 FY
Annual report (foreign)
5 Apr 12
Current reports
6-K
Current report (foreign)
27 May 21
6-K
Current report (foreign)
30 Mar 21
6-K
Current report (foreign)
26 Mar 21
6-K
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
5 Jan 21
6-K
Current report (foreign)
8 Dec 20
6-K
Current report (foreign)
24 Nov 20
6-K
Current report (foreign)
17 Nov 20
6-K
Current report (foreign)
28 Oct 20
6-K
Current report (foreign)
28 Oct 20
6-K
Current report (foreign)
25 Aug 20
Registration and prospectus
S-8
Registration of securities for employees
12 Feb 21
F-3
Shelf registration (foreign)
6 Jul 20
F-3
Shelf registration (foreign)
21 Apr 15
S-8
Registration of securities for employees
10 Apr 14
S-8
Registration of securities for employees
21 Jun 12
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Apr 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Apr 11
S-8
Registration of securities for employees
5 May 10
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Sep 09
424B5
Prospectus supplement for primary offering
7 Apr 08
Proxies
No filings
Other
EFFECT
Notice of effectiveness
16 Jul 20
CORRESP
Correspondence with SEC
12 Jul 20
UPLOAD
Letter from SEC
9 Jul 20
EFFECT
Notice of effectiveness
10 May 17
CORRESP
Correspondence with SEC
8 May 17
UPLOAD
Letter from SEC
26 Apr 15
UPLOAD
Letter from SEC
25 Jan 11
CORRESP
Correspondence with SEC
19 Dec 10
UPLOAD
Letter from SEC
22 Nov 10
CORRESP
Correspondence with SEC
4 Nov 10
Ownership
SC 13G/A
TRINITY BIOTECH / Whitefort Capital Master Fund ownership change
16 Feb 21
SC 13G/A
TRINITY BIOTECH / STONEHILL CAPITAL MANAGEMENT ownership change
12 Feb 21
SC 13G
TRINITY BIOTECH / RENAISSANCE TECHNOLOGIES ownership change
10 Feb 21
SC 13G/A
TRINITY BIOTECH / STONEHILL CAPITAL MANAGEMENT ownership change
4 Sep 20
SC 13G/A
Trinity Biotech PLC
14 Feb 20
SC 13G/A
Trinity Biotech PLC
14 Feb 20
SC 13G/A
Trinity Biotech PLC
7 Feb 20
SC 13G/A
Trinity Biotech PLC
8 Jul 19
SC 13G
Trinity Biotech PLC
3 May 19
SC 13G/A
Trinity Biotech PLC
14 Feb 19